Doctor Admits of Leaking Safety Information to GSK
February 1, 2008
WASHINGTON, Jan. 30 — Citing a bad case of poor judgment, an independent reviewer for the New England Journal of Medicine has conceded that he leaked privileged information to GlaxoSmithKline last May on a meta-analysis that cast the company’s diabetes drug rosiglitazone (Avandia) in a bad light.
Popularity: 43% [?]
Doctor Accused of Leak to Drug Maker
January 31, 2008
The New York Times is on fire today with great articles about the pharmaceuticals.
A leading member of the Senate said Wednesday that a prominent diabetes expert had leaked an unpublished and confidential medical journal article to GlaxoSmithKline last year, tipping the company to the imminent publication of safety questions involving the company’s diabetes drug Avandia.
Popularity: 55% [?]
